Scilex closes $15M registered direct offering of 15M shares and warrants

Scilex Holding Co

Offering of 15,000,000 common shares plus warrants to purchase 15,000,000 shares at $1.00/unit.
Warrants exercisable at $1.10/share starting six months from issuance, expiring in five years.
Gross proceeds $15 million before placement agent fees and expenses; offering closed April 25, 2024.
Net proceeds for working capital, R&D, commercialization, and possible debt/stock repurchases.
Placement agents received 8% cash fee and warrants to purchase 1,200,000 shares at $1.25/share.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Scilex Holding Co entered into Purchase Agreement with the investor named therein valued at $15,000,000 (effective 2024-04-23).

Action: entry
Agreement: equity purchase
Counterparty: the investor named therein
Value: $15,000,000
Effective: 2024-04-23

Exact text from the filing

On April 23, 2024, Scilex Holding Company (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the investor named therein, pursuant to which the Company agreed to sell and issue, in a registered direct offering (the “Offering”): (i) an aggregate of 15,000,000 shares of its common stock (the “Shares”), and (ii) common warrants to purchase up to 15,000,000 shares of its common stock

View on SEC.gov

317 material agreements filed in the last 30 days. Browse all material agreements →

Scilex Holding Co filing history →

Source: SEC EDGAR

accession 0001193125-24-114000

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.